Moch, Holger

Endothelial cell infection and endotheliitis in COVID-19

Varga, Z., Flammer, A. J., Steiger, P., Haberecker, M., Andermatt, R., Zinkernagel, A. S., Mehra, M. R., Schuepbach, R. A., Ruschitzka, F., & Moch, H. (2020) · The Lancet

COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 Research

Cited by 6,358

Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients

Bubendorf, L., Schöpfer, A., Wagner, U., Sauter, G., Moch, H., Willi, N., Gasser, T. C., & Mihatsch, M. J. (2000) · Human Pathology

Prostate Cancer Treatment and ResearchProstate Cancer Diagnosis and Treatment

Cited by 1,895

Chemokine receptor CXCR4 downregulated by von Hippel–Lindau tumour suppressor pVHL

Staller, P., Sulitkova, J., Lisztwan, J., Moch, H., Oakeley, E. J., & Krek, W. (2003) · Nature

Chemokine receptors and signalingCancer, Hypoxia, and Metabolism

Cited by 870

Metabolic Activation of Intrahepatic CD8+ T Cells and NKT Cells Causes Nonalcoholic Steatohepatitis and Liver Cancer via Cross-Talk with Hepatocytes

Wolf, M. J., Adili, A., Piotrowitz, K., Abdullah, Z., Boege, Y., Stemmer, K., Ringelhan, M., Simonavicius, N., Egger, M., Wohlleber, D., et al. (2014) · Cancer Cell

Liver Disease Diagnosis and TreatmentLiver physiology and pathology

Cited by 678

Maturation of tertiary lymphoid structures and recurrence of stage II and III colorectal cancer

Posch, F., Silina, K., Leibl, S., Mündlein, A., Moch, H., Siebenhüner, A., Samaras, P., Riedl, J., Stotz, M., Szkandera, J., et al. (2018) · OncoImmunology

Cancer Immunotherapy and BiomarkersColorectal Cancer Treatments and Studies

Cited by 380

Sox10 promotes the formation and maintenance of giant congenital naevi and melanoma

Shakhova, O., Zingg, D., Schaefer, S. M., Hari, L., Civenni, G., Blunschi, J., Claudinot, S., Okoniewski, M., Beermann, F., Mihic-Probst, D., et al. (2012) · Nature Cell Biology

Melanoma and MAPK Pathwaysmelanin and skin pigmentation

Cited by 274

HLA Ligand Atlas: a benign reference of HLA-presented peptides to improve T-cell-based cancer immunotherapy

Marcu, A., Bichmann, L., Kuchenbecker, L., Kowalewski, D. J., Freudenmann, L. K., Backert, L., Mühlenbruch, L., Szolek, A., Lübke, M., Wagner, P., et al. (2021) · Journal for ImmunoTherapy of Cancer

vaccines and immunoinformatics approachesImmunotherapy and Immune Responses

Cited by 250

Two distinct immunopathological profiles in autopsy lungs of COVID-19

Nienhold, R., Ciani, Y., Koelzer, V. H., Tzankov, A., Haslbauer, J. D., Menter, T., Schwab, N., Henkel, M., Frank, A., Zsikla, V., et al. (2020) · Nature Communications

COVID-19 Clinical Research StudiesSARS-CoV-2 and COVID-19 Research

Cited by 246

The Value of In Vitro Diagnostic Testing in Medical Practice: A Status Report

Rohr, U.-P., Binder, C., Dieterle, T., Giusti, F., Messina, C. G. M., Toerien, E., Moch, H., & Schäfer, H. H. (2016) · PLOS ONE

Healthcare cost, quality, practicesClinical Laboratory Practices and Quality Control

Cited by 229

Senescence Reprogramming by TIMP1 Deficiency Promotes Prostate Cancer Metastasis

Guccini, I., Revandkar, A., D'Ambrosio, M., Colucci, M., Pasquini, E., Mosole, S., Troiani, M., Brina, D., Sheibani-Tezerji, R., Elia, A. R., et al. (2021) · Cancer Cell

Telomeres, Telomerase, and SenescenceProstate Cancer Treatment and Research

Cited by 185

PD-L1 expression is regulated by hypoxia inducible factor in clear cell renal cell carcinoma

Ruf, M., Moch, H., & Schraml, P. (2016) · International Journal of Cancer

Cancer Immunotherapy and BiomarkersCancer, Hypoxia, and Metabolism

Cited by 179

Frequent PD-L1 Expression in Testicular Germ Cell Tumors

Fankhauser, C. D., Curioni-Fontecedro, A., Allmann, V, Beyer, J., Tischler, V, Sulser, T., Moch, H., & Bode, P. K. (2015) · British Journal of Cancer

Cancer Immunotherapy and BiomarkersTesticular diseases and treatments

Cited by 174

Amplification pattern of 12q13–q15 genes (MDM2, CDK4, GLI) in urinary bladder cancer

Simon, R., Struckmann, K., Schraml, P., Wagner, U., Forster, T., Moch, H., Fijan, A., Bruderer, J., Wilber, K., Mihatsch, M. J., et al. (2002) · Oncogene

Bladder and Urothelial Cancer TreatmentsUrinary and Genital Oncology Studies

Cited by 157

Combined mutation in Vhl, Trp53 and Rb1 causes clear cell renal cell carcinoma in mice

Harlander, S., Schönenberger, D., Toussaint, N. C., Prummer, M., Catalano, A., Brandt, L., Moch, H., Wild, P. J., & Frew, I. J. (2017) · Nature Medicine

Renal cell carcinoma treatmentCancer, Hypoxia, and Metabolism

Cited by 143

Autoantibodies against β‐amyloid are common in Alzheimer's disease and help control plaque burden

Kellner, A., Matschke, J., Bernreuther, C., Moch, H., Ferrer, I., & Glatzel, M. (2009) · Annals of Neurology

Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration Mechanisms

Cited by 113

Antagonistic Cross-Regulation between Sox9 and Sox10 Controls an Anti-tumorigenic Program in Melanoma

Shakhova, O., Cheng, P., Mishra, P. J., Zingg, D., Schaefer, S. M., Debbache, J., Häusel, J., Matter, C., Guo, T., Davis, S., et al. (2015) · PLOS Genetics

Melanoma and MAPK PathwaysCutaneous Melanoma Detection and Management

Cited by 111

Pancreatic Endocrine Tumors are a Rare Manifestation of the Neurofibromatosis Type 1 Phenotype: Molecular Analysis of a Malignant Insulinoma in a NF-1 Patient

Perren, A., Wiesli, P., Schmid, S., Montani, M., Schmitt, A., Schmid, C., Moch, H., & Komminoth, P. (2006) · The American Journal of Surgical Pathology

Neuroendocrine Tumor Research AdvancesNeurofibromatosis and Schwannoma Cases

Cited by 84